company background image
4527 logo

Rohto PharmaceuticalLtd TSE:4527 Stock Report

Last Price

JP¥2.78k

Market Cap

JP¥629.9b

7D

2.0%

1Y

-9.9%

Updated

03 Jun, 2024

Data

Company Financials +

Rohto Pharmaceutical Co.,Ltd.

TSE:4527 Stock Report

Market Cap: JP¥629.9b

4527 Stock Overview

Manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide.

4527 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance3/6
Financial Health5/6
Dividends3/6

Rohto Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rohto PharmaceuticalLtd
Historical stock prices
Current Share PriceJP¥2,778.00
52 Week HighJP¥4,117.00
52 Week LowJP¥2,640.50
Beta-0.094
1 Month Change-9.33%
3 Month Change-7.20%
1 Year Change-9.86%
3 Year Change102.26%
5 Year Change85.20%
Change since IPO1,202.70%

Recent News & Updates

Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

May 14
Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

Recent updates

Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

May 14
Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Apr 03
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Mar 21
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Feb 26
Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Shareholder Returns

4527JP Personal ProductsJP Market
7D2.0%-0.2%1.0%
1Y-9.9%-4.2%24.0%

Return vs Industry: 4527 underperformed the JP Personal Products industry which returned -4.2% over the past year.

Return vs Market: 4527 underperformed the JP Market which returned 24% over the past year.

Price Volatility

Is 4527's price volatile compared to industry and market?
4527 volatility
4527 Average Weekly Movement4.6%
Personal Products Industry Average Movement4.2%
Market Average Movement4.0%
10% most volatile stocks in JP Market7.7%
10% least volatile stocks in JP Market2.2%

Stable Share Price: 4527 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4527's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18997,176Yamada Kuniowww.rohto.co.jp

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.

Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Rohto PharmaceuticalLtd's earnings and revenue compare to its market cap?
4527 fundamental statistics
Market capJP¥629.89b
Earnings (TTM)JP¥30.94b
Revenue (TTM)JP¥270.84b

20.5x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4527 income statement (TTM)
RevenueJP¥270.84b
Cost of RevenueJP¥113.55b
Gross ProfitJP¥157.29b
Other ExpensesJP¥126.35b
EarningsJP¥30.94b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)135.60
Gross Margin58.07%
Net Profit Margin11.42%
Debt/Equity Ratio4.2%

How did 4527 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

20%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.